Martis Capital is a private equity firm that invests in middle-market healthcare companies.

Martis Capital

Martis Capital is a middle-market private equity fund focused exclusively on the North American healthcare industry.

Located in San Francisco, CA and Washington, DC, the Martis Capital team leverages more than 125 years of financial and clinical experience, as well as a deep relationship network of healthcare executives and institutions, to help evaluate investment opportunities and support our portfolio companies.

AAIPharma Services

Altruista Health, Inc.

Performance Health

Credible

HealthPlan Services

Healthy Living Network

More great news from WellHaven Pet Health!

Fantastic news from the team at WellHaven Pet Health!

Wednesday News! Alcanza Clinical Research is pleased to announce our newest acquisition, Kansas City Research Institute. This significant step forward underscores our commitment to advancing clinical research. By joining forces, we strengthen our capacity to drive cutting-edge treatments and expand our impact in Kansas City and beyond.
Learn more about our acquisition here: https://lnkd.in/eNyY3Wrb

Great news from the team at Alcanza Clinical Research. Read more here: https://lnkd.in/gce9qQ2X

Martis has opened an office in Miami and hired two senior team members! Please join us in welcoming Elizabeth Dresdale and David Muckey. Read more here:

https://lnkd.in/g6ZCQXYz

We're thrilled to share that Martis has been named to Inc's 2023 Founder-Friendly Investors list. Of the 218 firms honored, Martis was one of eight healthcare-exclusive private equity firms listed and one of only three healthcare-exclusive firms to be recognized for a third consecutive year.

Read more here:

https://lnkd.in/dqeuZjZB

Metric
Company Name	Martis Capital
Symbol
MSH ID	COM:MARTISCAPITAL
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Private Equity
Country	US
Stage
Employee Count	38
Website	martiscapital.com
LinkedIn	martis-capital
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

MART

COM:MARTISCAPITAL

Martis Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue